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Background
Identifying the functional consequences of Wnt/β-
catenin signaling in mammary stem cell populations is 
critically important for understanding the contribution 
of this pathway to mammary tumorigenesis. Th  ere is 
abundant evidence that hyperactivation of the canonical 
Wnt signaling pathway promotes tumorigenesis in 
experi  mental systems, while observational data 
demonstrate that the pathway is frequently activated in 
human breast tumors, especially in basal-like carcinomas, 
one of the most aggressive forms of the disease [1-3]. 
MMTV-Wnt1 transgenic mice provide a powerful model 
of Wnt signaling in mammary cancer, and also one in 
which the role of aberrant stem cell behavior may be 
paramount [4,5]. Th   ese mice develop premalignant 
mammary hyperplasia with elevated stem cell numbers 
[6], and their subsequent carcinomas contain a cancer 
stem cell population deﬁ  ned by methods similar to those 
applied to human breast cancers [7]. Meanwhile, studies 
of stem cells in other tissues, such as bone marrow, skin, 
and intestine, have strongly implicated Wnt/β-catenin 
signaling as a pathway that fosters the self-renewal, 
maintenance, and/or expansion of stem cells or multi-
potent precursors [1,8,9]. However, details at the cellular 
level remain to be established in each tissue, as do the 
downstream mechanisms through which Wnt signaling 
acts in each context.
Viewpoint
In a paper recently published in Cell Stem Cell [10], Zeng 
and Nusse made use of the epithelial cell surface marker 
phenotype CD24+ and CD29hi that identiﬁ  es a population 
highly enriched for mouse mammary stem cells (MaSCs) 
[11]. Th  e authors isolated these cells by ﬂ  uorescence 
activated cell sorting (FACS) from mammary tissue and 
cultured them in matrigel, serum-free medium, and epi-
dermal growth factor. Under these conditions, the cells 
formed clonal colonies containing diﬀ  erentiated cells as 
well as cells capable of generating new colonies upon 
serial passage. When puriﬁ  ed Wnt3a protein was added 
to the primary cultures, the number of cells able to form 
secondary colonies was increased 2.5-fold relative to 
vehicle-treated controls [10]. Th  is expansion continued 
through multiple passages, yet the Wnt treatment had no 
obvious eﬀ  ect on the growth rate of individual colonies 
or their composition of diﬀ  erentiated cell types. Impor-
tantly, the Wnt-treated colonies retained their mammary 
gland reconstitution eﬃ   ciency upon transplantation in 
vivo, conﬁ   rming that deﬁ   nitive stem cell capacity was 
maintained as the relevant cells increased their numbers 
in culture.
Th   e most important aspect of these results is the likely 
conclusion that Wnt proteins can act directly on MaSCs 
to promote their self-renewal or expansion. A direct 
response is further supported by evidence that some of 
the individual stem cells in vivo display activation of a 
Wnt-responsive lacZ reporter [10]. Previous data impli-
cating Wnt signaling in the regulation of mammary stem 
cells  in vivo could not generally distinguish between 
direct versus indirect eﬀ  ects (for example, on the stem 
cell niche). Th  e present results also address temporal 
issues of cell fate control. Rather than causing a 
permanent change aﬀ  ecting all future cell divisions, the 
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nance of the self-renewing stem cell population [10]. Th  is 
may reﬂ  ect the eﬀ  ective absence of a niche in the culture 
conditions and a default tendency towards lineage 
diﬀ  erentiation. In contrast, once the Wnt-treated cells 
were transplanted in vivo, their self-renewal was 
maintained through serial transplants. Th   is suggests that 
they found, or generated, a suitable niche in vivo, perhaps 
one that provides sustained Wnt signaling.
One interpretation of these results is that Wnt signals 
can replace the need for a physical stem cell niche. If 
something comparable takes place in MMTV-Wnt1 
mammary tumors, in which Wnt signaling is constitu-
tively activated, this could explain the prominence of 
stem cell transcriptional signatures in such tumors [12]. 
It is particularly pertinent to ask whether eﬀ  ects  of 
aberrant Wnt signaling on cancer stem cells might under-
lie the aggressive phenotype of basal-like human breast 
cancers [3,7].
Another question that arises from Zeng and Nusse’s 
results concerns the mechanisms by which Wnt signals 
promote the self-renewal of MaSCs. A standard approach 
to this would be to scrutinize, in the stem cell population, 
transcriptional targets of the T cell factor (TCF)-β-
catenin complexes through which canonical Wnt signals 
act in the nucleus [1,8]. Of several Wnt target genes that 
have been reported in mammary cells, a particularly 
intriguing candidate, LBH, has recently been described in 
Molecular and Cellular Biology [13].
LBH is a transcription cofactor named for its abundant 
expression in embryonic limb bud and heart, although it 
is also expressed in the mouse mammary gland [13,14]. 
Its expression in mouse limb bud ectoderm is largely 
coincident with canonical Wnt signaling and this 
prompted Rieger and colleagues [13] to ask if it might be 
a Wnt target gene. Th  eir data comprehensively demon-
strate that Lbh is a direct transcriptional target of TCF-β-
catenin. Th  is was borne out in the mammary cell line 
HC11, in which Wnt3a treatment induced endogenous 
Lbh expression. Moreover, exogenous expression of Lbh 
in HC11 prevented lactogenic diﬀ  erentiation, something 
that is also prevented by Wnt signaling in these cells 
[13,15]. Th   is raises a possible connection between Wnt-
mediated inhibition of stem/precursor cell diﬀ  erentiation 
and the functions of Lbh, whose overexpression in 
cardiac and other tissues has been associated with 
prolonged maintenance of immature cells at the expense 
of diﬀ  erentiation [13].
Turning to mammary tumors, Rieger and colleagues 
documented signiﬁ  cant levels of Lbh mRNA in MMTV-
Wnt1 mammary tumors. Th   ey also found high levels of 
LBH in estrogen receptor-negative human breast cancer 
cell lines of basal origin that have active endogenous Wnt 
signaling. Next they interrogated Aﬀ  ymetrix data from 
human breast carcinomas and found LBH was most 
frequently associated with basal-type tumors, the form 
also associated with Wnt pathway activation [3,13].
Collectively, these data build a solid case for Lbh as a 
transcriptional target that responds to canonical Wnt 
signaling in mammary tissue and Wnt-driven tumors. Its 
prevalence in highly aggressive basal-like human 
carcinomas makes it of particular clinical interest, at least 
as a marker, and conceivably as a therapeutic target in 
these diﬃ   cult to treat tumors if it plays a role in their 
proliferation. Th   ere is preliminary evidence that Lbh may 
act as one of the functional mediators of Wnt signaling in 
the inhibition of HC11 cell diﬀ  erentiation, but these are 
early days for this newly revealed Wnt target [13].
A key question for this Viewpoint is whether Lbh is a 
TCF-β-catenin target gene in the mammary stem cells in 
which Zeng and Nusse describe the self-renewal eﬀ  ects 
of Wnt signaling. While this remains to be determined 
deﬁ  nitively, it is striking that a recent paper in Breast 
Cancer Research lists Lbh/LBH as one of the genes in a 
conserved gene expression signature characteristic of 
mammary stem cells in both mouse and human [12]. Th  is 
raises the intriguing possibility that Lbh is one of the 
targets that mediate the functional eﬀ   ects of Wnt 
signaling on mammary tissue stem cells, and perhaps on 
stem-like cells in breast cancer.
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